As in adults, migraine surgery is effective for selected adolescent patients with severe migraine headaches that don’t respond to standard treatments, reports a new study.
SOURCE: Children’s Health News — ScienceDaily – Read entire story here.
Related posts:
- Racial socialization in early childhood may increase child’s ability to excel in school A child's ability to succeed academically is one of the strongest determinants of his or her future quality of life. In particular, it has been directly linked to overall longevity and several other critical health outcomes. ...
- Workplace intervention improves sleep of employees’ children A workplace intervention designed to reduce employees' work-family conflict and increase schedule flexibility also has a positive influence on the sleep patterns of the employees' children, researchers report. ...
- Hodgkin’s lymphoma: Treatment can have late sequelae In Hodgkin's lymphoma -- cancer of the lymph nodes -- nine out of ten patients survive the disease, thanks to the highly effective treatments that are now available. Depending on the type of treatment given, however, there may be late sequelae, researchers report. These authors studied the question of which types of treatment were more likely to be followed by the development of secondary malignant neoplasia, and they quantified the risk of such an event as a function of the treatment received. ...
- Before an operation, low blood pressure rather than high is a risk factor for death New research suggests that, before an operation, low blood pressure rather than high blood pressure is an independent risk factor for death. ...
- Targeted drug can ‘diminish the suffering’ of myelofibrosis Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a researcher who co-led PERSIST-1, the worldwide phase 3 clinical trial that tested the therapy. Specifically, pacritinib substantially reduced severe enlargement of the spleen, a typical feature of advanced myelofibrosis, in more than 20 percent of patients and alleviated debilitating side effects in more than 46 percent. ...
